glp-1 and cancer risk Agents vs Aspirin: A New Era in Colorectal Prevention Emerging Evidence Positions GLP-1 Receptor
Description
No separate membership or consultation charges
.png?w=1536&max-h=2752&fit=crop&auto=format)
Cardiovasc Ther
H188 exhibited wide dynamic range (2-fold FRET), high sensitivity (EC 50 500 nM), and excellent Z-score (0.77) when testing forskolin
Association Between GLP-1 Receptor Agonists and Incidence of Lung Cancer in Treatment-Naive Type 2 Diabetes
A phase 2 52-week study reports a mean weight loss of 17% and 20% in participants with and without T2D, respectively (71)
